EX-99.1
2
simulations_8k-ex9901.txt
PRESS RELEASE
EXHIBIT 99.1
SIMULATIONS PLUS
Integrating Science and Software
For Further Information:
SIMULATIONS PLUS, INC.
1220 W. Avenue J
Lancaster, CA 93534-2902
661.723.7723
www.simulations-plus.com
CONTACT:
Investor Relations
Ms. Renee Bouche
Simulations Plus, Inc.
661.723.7723
info@simulations-plus.com
For Immediate Release:
November 28, 2005
SIMULATIONS PLUS ANNOUNCES CHANGE IN INVESTOR RELATIONS
FUNCTION TO BE MOVED IN-HOUSE FOR GREATER OPERATING EFFICIENCY
LANCASTER, CA, NOVEMBER 28, 2005 --Simulations Plus, Inc. (AMEX: SLP), the
leading provider of ADMET absorption simulation and structure-to-property
prediction software for pharmaceutical discovery and development, announced
today that it has terminated its former investor relations agreement with
Cameron and Associates and will move this function in-house.
Walt Woltosz, chairman and chief executive officer of Simulations Plus,
said, "As the company has grown and we have learned more about how to handle
investor relations issues, we have decided to do as many other companies have
done and bring this function in-house. We believe that this will provide greater
shareholder value through both a significant cost savings, as well as allowing a
greater number of person-hours to be applied to this function to provide a more
active IR program".
ABOUT SIMULATIONS PLUS, INC.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery
and development simulation software, which is licensed to and used in the
conduct of drug research by major pharmaceutical and biotechnology companies
worldwide. The Company has two other businesses, Words+, Inc. and FutureLab(TM),
which are based on its proprietary software technologies. Simulations Plus,
Inc., is headquartered in Southern California. For more information, visit our
Web site at www.simulations-plus.com.
###
5

EX - 99 . 1 2 simulations _ 8k - ex9901 . txt PRESS RELEASE EXHIBIT 99 . 1 SIMULATIONS PLUS Integrating Science and Software For Further Information : SIMULATIONS PLUS , INC . 1220 W . Avenue J Lancaster , CA 93534 - 2902 661 . 723 . 7723 www.simulations-plus.com CONTACT : Investor Relations Ms . Renee Bouche Simulations Plus , Inc . 661 . 723 . 7723 info@simulations-plus.com For Immediate Release : November 28 , 2005 SIMULATIONS PLUS ANNOUNCES CHANGE IN INVESTOR RELATIONS FUNCTION TO BE MOVED IN - HOUSE FOR GREATER OPERATING EFFICIENCY LANCASTER , CA , NOVEMBER 28 , 2005 -- Simulations Plus , Inc . ( AMEX : SLP ) , the leading provider of ADMET absorption simulation and structure - to - property prediction software for pharmaceutical discovery and development , announced today that it has terminated its former investor relations agreement with Cameron and Associates and will move this function in - house . Walt Woltosz , chairman and chief executive officer of Simulations Plus , said , " As the company has grown and we have learned more about how to handle investor relations issues , we have decided to do as many other companies have done and bring this function in - house . We believe that this will provide greater shareholder value through both a significant cost savings , as well as allowing a greater number of person - hours to be applied to this function to provide a more active IR program " . ABOUT SIMULATIONS PLUS , INC . Simulations Plus , Inc . , is a premier developer of groundbreaking drug discovery and development simulation software , which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide . The Company has two other businesses , Words + , Inc . and FutureLab ( TM ) , which are based on its proprietary software technologies . Simulations Plus , Inc . , is headquartered in Southern California . For more information , visit our Web site at www.simulations-plus.com . # # # 5